Hookipa Pharma Stock Technical Analysis
| HOOK Stock | USD 2.52 0.04 1.61% |
As of the 1st of December, Hookipa Pharma retains the Risk Adjusted Performance of (0.19), standard deviation of 3.82, and Market Risk Adjusted Performance of (1.06). Hookipa Pharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hookipa Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Hookipa, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HookipaHookipa |
Hookipa Pharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.82 | Strong Buy | 4 | Odds |
Most Hookipa analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Hookipa stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Hookipa Pharma, talking to its executives and customers, or listening to Hookipa conference calls.
Hookipa Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Hookipa Pharma Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Hookipa Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Hookipa Pharma Trend Analysis
Use this graph to draw trend lines for Hookipa Pharma. You can use it to identify possible trend reversals for Hookipa Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Hookipa Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Hookipa Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Hookipa Pharma applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that Hookipa Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 58.69, which is the sum of squared deviations for the predicted Hookipa Pharma price change compared to its average price change.About Hookipa Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Hookipa Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Hookipa Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Hookipa Pharma price pattern first instead of the macroeconomic environment surrounding Hookipa Pharma. By analyzing Hookipa Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Hookipa Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Hookipa Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 3.69 | 4.13 | 3.5 | 3.33 | Net Debt To EBITDA | 0.8 | 1.77 | 1.43 | 2.71 |
Hookipa Pharma December 1, 2024 Technical Indicators
Most technical analysis of Hookipa help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Hookipa from various momentum indicators to cycle indicators. When you analyze Hookipa charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (1.06) | |||
| Mean Deviation | 2.81 | |||
| Coefficient Of Variation | (378.92) | |||
| Standard Deviation | 3.82 | |||
| Variance | 14.62 | |||
| Information Ratio | (0.30) | |||
| Jensen Alpha | (1.14) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (1.07) | |||
| Maximum Drawdown | 22.98 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 6.85 | |||
| Skewness | (0.44) | |||
| Kurtosis | 2.58 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share 4.403 | Quarterly Revenue Growth (0.52) | Return On Assets (0.20) | Return On Equity (0.49) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.